BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 240 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,690,000 | -22.4% | 97,175 | -25.2% | 0.08% | -19.4% |
| Q2 2022 | $18,930,000 | +98.2% | 129,919 | +61.3% | 0.10% | +81.5% |
| Q1 2022 | $9,551,000 | -43.2% | 80,552 | -33.9% | 0.05% | -41.3% |
| Q4 2021 | $16,805,000 | -33.5% | 121,946 | -33.0% | 0.09% | -43.6% |
| Q3 2021 | $25,268,000 | +2120.4% | 181,904 | +1451.2% | 0.16% | +1937.5% |
| Q2 2021 | $1,138,000 | -33.2% | 11,727 | -53.0% | 0.01% | -33.3% |
| Q1 2021 | $1,704,000 | -22.8% | 24,930 | -3.1% | 0.01% | -36.8% |
| Q4 2020 | $2,206,000 | -49.3% | 25,735 | -61.6% | 0.02% | -47.2% |
| Q3 2020 | $4,355,000 | -31.9% | 66,996 | -23.4% | 0.04% | -50.7% |
| Q2 2020 | $6,394,000 | +2135.7% | 87,453 | +941.1% | 0.07% | +812.5% |
| Q1 2020 | $286,000 | -57.1% | 8,400 | -35.2% | 0.01% | -60.0% |
| Q1 2019 | $667,000 | – | 12,964 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |